NCDR ICD Registry V2.1 Data Collection Form Generator & Leads
|
|
|
- Willis Shepherd
- 9 years ago
- Views:
Transcription
1 A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : Race: B. EPISODE OF CARE (ADMISSION) Sex 2060 : O Male O Female Hispanic or Latino Ethnicity 2076 : White 2070 Black/African American 2071 Asian 2072 American Indian/Alaskan Native 2073 Native Hawaiian/Pacific Islander 2074 Arrival Date 3000 : Reason for Admission 3010 : Insurance Payor(s): HIC 3030 : Patient Zip Code 3005 : Zip Code NA 3006 O Admitted for this procedure O Cardiac - Heart Failure O Cardiac - Other n-cardiac Private Health Insurance 3020 Medicare 3021 Medicaid 3022 Military Health Care 3023 State-Specific Plan (Non-Medicaid) 3024 Indian Health Service 3025 Non-US Insurance 3026 None 3027 C. HISTORY AND RISK FACTORS (COMPLETE ONLY ONCE FOR EPISODES OF CARE/ADMISSIONS WITH A GENERATOR IMPLANT OR CHANGE) Heart Failure 4000 : If Yes, Duration of Symptoms Since Initial Onset 4005 : If Yes, Prior Heart Failure Hospitalization 4010 : O < 3 months O 3 to 9 months O > 9 months NYHA Functional Classification 4020 : Non-Ischemic Dilated Cardiomyopathy 4025 : Prior Heart Transplant 4035 : On Heart Transplant Waiting List 4040 : Atrial Fibrillation/Flutter 4055 : Ventricular Tachycardia 4065 : Cardiac Arrest 4080 : Syncope 4045 : Family History of Sudden Death 4050 : If Yes, AFib/Flutter Classification 4060 : O Paroxysmal O Persistent (> 7 days) O Permanent (> 1 year) O Secondary (reversible cause) O Unknown If Yes, Hemodynamic Instablility 4070 : If Yes, VT Type 4075 : If Yes, VTach/VFib Arrest 4090 : If Yes, Bradycardia Arrest 4095 : Syndromes w/risk of Sudden Death 4100 : If Yes, Syndrome Type 4105 : Previous ICD 4110 : If Yes, Prior HF Hospital Timeframe 4015 : If Yes, Type 4115 : If Yes, Previous ICD Date 4125 : If Yes, Previous ICD Reason 4130 : If Yes, Previous ICD Implant Site 4120 : O <= 6 months O Unknown If Yes, Timeframe 4030 : O > 6 months O Class I O Class II O Class III O Class IV n-sustained VT O Sustained monomorphic VT O Sustained polymorphic VT O Sustained monomorphic and polymorphic VT O Unknown O Unknown If Yes, Most Recent Arrest Date 4085 : O < 3 months O 3 to 9 months O >9 months O Unknown O Long QT syndrome O Short QT syndrome O Brugada syndrome O Catecholaminergic polymorphic VT O Idiopathic/Primary VT/VF O Single chamber O Dual chamber O CRT-D O Pectoral O Primary prevention O Abdominal If Secondary Prevention, Reason(s) for Initial Implant: O Secondary prevention If Primary Prevention, Implant Decision LVEF 4135 : % LVEF Not Available 4136 Cardiac Arrest/Arrhythmia-Etiology Unknown 4140 Spontaneous Sustained VT 4141 Syncope with High Risk Characteristics 4142 Syncope with Inducible VT 4143 Ventricular Fibrillation 4144 Not Documented 4145 According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is The time required to complete this information collection is estimated to average fifteen (15) minutes per response, including the time to review instructions, search existing data resources, gather the data needed, and complete and review the information collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: CMS, 7500 Security Boulevard, Attn: PRA Reports Clearance Officer, Mail Stop C , Baltimore, Maryland American College of Cardiology Foundation 2/23/2010 Page 1 of 5
2 Permanent Pacemaker 4150 : Prior MI 4170 : If Yes, Most Recent MI Timeframe 4175 : Prior PCI 4180 : If Yes, Pacemaker Type 4155 : Ischemic Heart Disease 4160 : Prior CABG 4190 : Other Structural Abnormalities 4205 : If Yes, Structural Abnormality Type(s): Cerebrovascular Disease 4235 : Chronic Lung Disease 4240 : Diabetes Mellitus 4245 : (Prior to arrival) (Prior to arrival) Currently on Dialysis 4255 : Hypertension 4260 : Patient Life Expectancy of >=1 Year 4270 : If Yes, Most Recent PCI Date 4185 : If Yes, Most Recent CABG Date 4195 : Height 4225 : cm Weight 4230 : kg Sleep Apnea 4250 : t assessed t documented NCDR ICD Registry V2.1 O <= 40 days O > 40 days Amyloidosis 4210 Atrial Septal Defect 4211 Chagas Disease 4212 Common Ventricle 4213 Ebstein s Anomaly 4214 Giant Cell Myocarditis 4215 Hypertrophic Cardiomyopathy (HCM) 4216 Left Ventricular Aneurysm 4217 LV Non-compaction Syndrome 4218 Right Ventricular Dysplasia (ARVD) 4219 Sarcoidosis 4220 Transposition of Great Vessels 4221 Tetralogy of Fallot 4222 Ventricular Septal Defect 4223 Other 4224 OTHER RISK FACTORS (By physician estimate) D. DIAGNOSTIC STUDIES (COMPLETE ONLY ONCE FOR EPISODES OF CARE/ADMISSIONS WITH A GENERATOR IMPLANT OR CHANGE.) LVEF Assessed 5000 : If Yes, Most Recent LVEF 5005 : % If Yes, Most Recent LVEF Timeframe 5010 : Electrophysiology Study 5015 : If Yes, EP Study Timeframe 5020 : If Yes, Ventricular Arrhythmias Induced 5025 : O Results Unattainable If Yes, VT Ablation Performed 5030 : If Yes, EP Study Finding(s): 12 Lead ECG w/automated Measurements 5040 : If Yes, ECG Date 5045 : O <1 month O 1 to 3 months O > 3 to 6 months O >6 months O <1 month O 1 to 3 months O > 3 to 6 months O >6 months Non-sustained VT 5031 Sustained Monomorphic VT 5032 Sustained Polymorphic VT 5033 Ventricular Flutter 5034 Ventricular Fibrillation 5035 (Most recent EP Study) PR Interval 5055 : msec PR Interval Not Obtainable 5056 (Exclude atrial fib, 2 nd or 3rd heart block, vent pacing) QRS Duration (Non-Ventricular Paced Complex) 5060 : msec Only Ventricular Paced QRS Complexes Present 5061 Cardiac Rhythm(s): If Paced, Underlying Atrial Rhythm 5075 : If Paced, Pacing Type 5080 : If Yes, One Epicardial Artery >=70% Confirmed by Angiography 4165 : Primary Valvular Heart Disease 4200 : (Includes previously placed) O Atrial chamber O Ventricular chamber O Dual chamber O CRT (Moderate to Severe) If Ventricular pacing or Both, Ventricular Paced QRS Duration 5085 : msec (From surface ECG closest to first generator procedure) AFib/Flutter 5065 Atrial Tachycardia 5066 Idioventricular 5067 Junctional 5068 Paced 5069 Sinus Rhythm 5070 Second Degree Heart Block 5071 Third Degree Heart Block 5072 O Sinus rhythm O Atrial fib/flutter O Sinus arrest O Unknown O Atrial pacing O Ventricular pacing O Both Abnormal Intraventricular Conduction 5090 : If Yes, Intraventricular Conduction Type(s): Left Anterior Fascicular Block 5095 Left Posterior Fascicular Block 5096 Left Bundle Branch Block (LBBB) 5097 Delay, Nonspecific 5098 Right Bundle Branch Block (RBBB) 5099 Ventricular Paced Rhythm American College of Cardiology Foundation 2/23/2010 Page 2 of 5
3 Blood Pressure 5105/5110 : Hemoglobin 5120 : Creatinine 5130 : BNP 5140 : / mmhg BUN 5115 : mg/dl 5116 Not Drawn g/dl Not Drawn 5121 Sodium 5125 : meq/l Not Drawn 5126 mg/dl Not Drawn 5131 Potassium 5135 : meq/l Not Drawn 5136 pg/ml E. PROCEDURE INFORMATION (COMPLETE FOR EACH LAB VISIT) Procedure Date/Time 6000/6001 : (OR) NT-proBNP 5145 : pg/ml Not Drawn 5146 Procedure Type 6005 : O Initial generator implant O Generator change O Lead only Prophylactic Antibiotics w/in 1 Hr of Procedure Start Time 6010 : not given, medical reason documented not given, reason unspecified Routine Warfarin (Coumadin) Therapy 6015 : (w/in 1 month) If Yes, Held for Procedure 6020 : If Yes, INR Drawn 6025 : If Yes, INR 6030 : If Yes, INR Drawn Date 6035 : Premarket Clinical Trial 6040 : If Yes, Clinical Trial Name 6045 : NCDR ICD Registry V2.1 F. ICD IMPLANT / EXPLANT (COMPLETE FOR EACH LAB VISIT IN WHICH AN INITIAL GENERATOR IMPLANT OR GENERATOR CHANGE WAS PERFORMED) (Closest to procedure) Operator s Name 6100,6105,6110 : NPI 6115 : ICD Indication 6125 : O Primary prevention O Secondary prevention Planned Device Type 6130 : O Single chamber O Dual chamber O CRT-D Device Implanted 6135 : If Yes, Final Device Type 6140 : O Single chamber O Dual chamber O CRT-D If CRT-D, CS/LV Lead Successful 6145 : t implanted O Previously implanted If Not Implanted, Reason CS/LV Lead Not Implanted 6150 : O Vascular access O Coronary sinus access O Tributary vein access O CS dissection O Unacceptable threshold O Diaphragmatic stimulation TIN 6120 : If Yes, ID 6155 : OR If Yes, Lowest Energy Tested (LET) that was Successful 6180 : Joules If Yes, Upper Limit of Vulnerability (ULV) 6185 : Manufacturer 6160 : If Yes, Serial Number 6175 : If Procedure Type 6005 = Generator Change Joules Model Name 6165 : Model Number 6170 : LET Not Tested 6181 ULV Not Tested 6186 Reason(s) for Re-Implantation: End of expected battery life 6190 Replaced at time of lead revision 6191 Upgrade 6192 Infection 6193 Under manufacturer advisory/recalled 6194 Faulty Connector/Header 6195 Device relocation 6196 Malfunction 6197 If Malfunction, Reason for Malfunction 6200 : O Atrial pacing O LV pacing O RV pacing ATP or Shock Therapy Delivered 6205 : If Yes, ATP or Shock Therapy Appropriate 6210 : If Yes, ATP Therapy Successful 6215 : If Yes, Shock Therapy Successful 6220 : Device Explanted 6225 : If Yes, Explant Date 6230 : If Yes, Device Returned To Manufacturer 6235 : If Yes, Battery Voltage 6240 : If Yes, ID 6245 : OR O Defibrillation If Yes, Serial Number 6250 : Voltage Not Available 6241 O Premature battery depletion (Code Yes even if prior to this procedure) Manufacturer 6160 : Model Name 6165 : Model Number 6170 : 2010 American College of Cardiology Foundation 2/23/2010 Page 3 of 5
4 G. LEAD ASSESSMENT (COMPLETE FOR ALL LEADS, INCLUDING NEW LEADS IMPLANTED, EXISTING LEADS EXTRACTED, ABANDONED, OR REUSED) Operator s Name 7000,7005,7010 : NPI 7015 : TIN 7020 : Lead Counter 7025 : 1 2 Identification 7030 : ID 7035 : OR Manufacturer 7040 : Model Name 7045 : 3 Model Number 7050 : Serial Number 7055 : Lead Location 7060 : COMPLETE FOR EXISTING LEADS ONLY Existing Lead Implant Date 7065 : Existing Lead Function 7070 : rmal O Abnormal t assessed Manufacturer Advisory/Recall 7075 : Existing Lead Status 7080 : If Extracted, Returned To Manufacturer 7085 : Existing Lead Placement Issues 7090 : If Yes, Dislodgement 7095 : If Yes, Perforation 7100 : If Yes, Erosion 7105 : If Yes, Faulty Connector/Header 7110 : If Yes, Patient s Clinical Status 7115 : If Yes, Infection 7120 : If Yes, Documented Infection 7125 : COMPLETE IF EXISTING LEAD FUNCTION 7070 IS ABNORMAL rmal O Abnormal t assessed rmal O Abnormal t assessed Pacing Issues 7130 : If Yes, Oversensing 7135 : If Yes, Undersensing 7140 : If Yes, Failure to Pace 7145 : If Yes, Failure to Capture with Acceptable Safety Margin 7150 : If Yes, Extracardiac Stimulation 7155 : Defibrillation Issues 7160 : If Yes, Oversensing w/shock or ATP 7165 : If Yes, Oversensing w/o Shock or ATP 7170 : If Yes, Failure to Shock with Inadequate DFT Safety Margin 7175 : Lead Integrity Issues 7180 : If Yes, Insulation Failure 7185 : If Yes, Conductor Failure 7190 : 2010 American College of Cardiology Foundation 2/23/2010 Page 4 of 5
5 H. INTRA OR POST PROCEDURE EVENTS (COMPLETE FOR EACH LAB VISIT) Intra or Post Procedure Events Occurred 8000 : If Yes, specify the Event(s): Cardiac Arrest 8005 : Myocardial Infarction 8055 : Drug Reaction 8010 : Pericardial Tamponade 8060 : Cardiac Perforation 8015 : Peripheral Embolus 8065 : Cardiac Valve Injury 8020 : Peripheral Nerve Injury 8070 : Conduction Block 8025 : Set Screw Problem 8075 : Coronary Venous Dissection 8030 : Pneumothorax 8080 : Hematoma (Req re-op, evacuation or transfusion) 8035 : TIA or Stroke (CVA) 8085 : Hemothorax 8040 : Urgent Cardiac Surgery 8090 : Infection Requiring Antibiotics 8045 : Venous Obstruction 8095 : Lead Dislodgement 8050 : I. DISCHARGE (COMPLETE FOR EACH EPISODE OF CARE/ADMISSION) CABG 9000 : (During this admission) PCI 9010 : Discharge Date 9020 : Discharge Status 9025 : Medication ACE Inhibitor (Any) 9045 Antiarrhythmic Agents Calcium Channel Blockers Amiodarone 9050 Disopyramide 9055 Dofetilide 9060 Flecainide 9065 Other 9070 ARB (Any) 9100 ASA (Any) 9105 (During this admission) Procainmide 9075 Propafenone 9080 Mexiletine 9085 Quinidine 9090 Sotalol 9095 Beta Blocker (Any) 9110 Diltiazem 9115 Other 9120 Verapamil 9125 If Deceased, Cause of Death 9030 : If Deceased, Death During the Procedure 9035 : If Alive, Discharged Against Medical Advice 9040 : O Alive O Cardiac If No, specify the Discharge Medication(s) Prescribed: Prescribed No Yes Con Blinded If Yes, CABG Date 9005 : If Yes, PCI Date 9015 : Digoxin (Any) 9130 Diuretic (Any) 9135 Hydralazine (Any) 9140 Lipid Lowering Agents Long Acting Nitroglycerin 9155 Platelet Aggregation Inhibitors O Deceased n-cardiac Medication Statin 9145 Non-Statin 9150 Clopidogrel 9160 Prasugrel 9165 Ticlopidine 9170 Warfarin (Coumadin) 9175 Prescribed No Yes Con Blinded 2010 American College of Cardiology Foundation 2/23/2010 Page 5 of 5
IHE Cardiology (CARD) White Paper. Cardiac Electrophysiology Key Data Elements
Integrating the Healthcare Enterprise IHE Cardiology (CARD) White Paper Cardiac Key Data Elements Date: August 5, 2011 Authors: IHE Cardiology Technical Committee Email: [email protected] CONTENTS Overview...
Automatic External Defibrillators
Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
NCDR ICD Registry V2.1 Coder's Data Dictionary
A. Demographics Seq. #: 2000 Name: Last Name Indicate the patient's last name. Hyphenated names should be recorded with a hyphen. Target Value: The value on arrival at this facility Seq. #: 2010 Name:
Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses
Diagnosis Code Crosswalk : to 402.01 Hypertensive heart disease, malignant, with heart failure 402.11 Hypertensive heart disease, benign, with heart failure 402.91 Hypertensive heart disease, unspecified,
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3
1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications
Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
Atrial Fibrillation Peter Santucci, MD Revised May, 2008
Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect Robert Kennedy, MD October 10, 2015 Definitions 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary.
Atrial Fibrillation The High Risk Obese Patient
Atrial Fibrillation The High Risk Obese Patient Frederick Schaller, D.O.,F.A.C.O.I. Professor and Vice Dean Touro University Nevada A 56 year old male with a history of hypertension and chronic stable
Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose
Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.
Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust
Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia
Adult Cardiac Surgery ICD9 to ICD10 Crosswalks
164.1 Malignant neoplasm of heart C38.0 Malignant neoplasm of heart 164.1 Malignant neoplasm of heart C45.2 Mesothelioma of pericardium 198.89 Secondary malignant neoplasm of other specified sites C79.89
Vascular Quality Initiative - Carotid Artery Stent. Last Name First Name Middle Initial
Vascular Quality Initiative - Carotid Artery Stent Last Name First Name Middle Initial Date of Birth Medical Record Social Security General Information Patient Data Zip/Postal Code Gender Male Female Ethnicity
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic
CARDIAC ELECTROPHYSIOLOGY, ARRHYTHMIAS AND PACING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational
Know the histology and gross anatomy of the normal sinoatrial node, atrial conduction pathways, atrioventricular (AV) junction and nod, His bundle, conduction fascicles and terminal intra-ventricular conduction
Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians
Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians May 19, 2015 Disclaimer This presentation is intended for educational use. Any duplication is prohibited without written consent
New in Atrial Fibrillation
New in Atrial Fibrillation September 2011 Stroke prevention more options Rhythm Control -drugs - alternatives to drugs; ablation Rate Control - pace + ablate A-FIB Dell Stroke Risk AFib Two Principles
Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center
Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long
Diagnostic and Therapeutic Procedures
Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,
ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY
Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF
Management of Pacing Wires After Cardiac Surgery
Management of Pacing Wires After Cardiac Surgery David E. Lizotte, Jr. PA C, MPAS, FAPACVS President, Association of Physician Assistants in Cardiovascular Surgery Conflicts: None Indications 2008 Journal
Cardioversion for. Atrial Fibrillation. Your Heart s Electrical System Cardioversion Living with Atrial Fibrillation
Cardioversion for Atrial Fibrillation Your Heart s Electrical System Cardioversion Living with Atrial Fibrillation When You Have Atrial Fibrillation You ve been told you have a heart condition called atrial
Atrial Fibrillation Centre
About this guide We have prepared this guide to help you to: learn about atrial fibrillation manage atrial fibrillation and reduce the risk of stroke find out about medicines and other treatment options
CCAD Training Manual. Cardiac Rhythm Management (CRM)
CCAD Training Manual Cardiac Rhythm Management (CRM) Version 1.0 A D Cunningham 19/3/2008 Introduction This manual is intended to assist users of the Notes Client version of the CCAD Cardiac Rhythm Management
INFORMATION FOR PATIENTS AND FAMILIES A Patient s Guide to Living with Atrial Fibrillation
INFORMATION FOR PATIENTS AND FAMILIES A Patient s Guide to Living with Atrial Fibrillation 30 Bond Street, Toronto, ON M5B 1W8 Canada 416.864.6060 stmichaelshospital.com Form No. XXXXX Dev. XX/XXXX GOALS
HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs)
HTEC 91 Medical Office Diagnostic Tests Week 4 Topic for Today: Atrial Rhythms PACs: Premature Atrial Contractions PAT: Paroxysmal Atrial Tachycardia AF: Atrial Fibrillation Atrial Flutter Premature Atrial
Perioperative Cardiac Evaluation
Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project
NCDR ACTION Registry - GWTG v2.4 Acute Coronary Treatment and Intervention Outcomes Network Registry
A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : SSN N/A 2031 Patient ID 2040 : Other ID 2045 : Birth Date 2050 : mm / dd / yyyy Sex 2060 : O Male O Female Patient Zip Code
Atrial Fibrillation An update on diagnosis and management
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
Basics of Pacing. Ruth Hickling, RN-BSN Tasha Conley, RN-BSN
Basics of Pacing Ruth Hickling, RN-BSN Tasha Conley, RN-BSN The Cardiac Conduction System Cardiac Conduction System Review Normal Conduction Conduction QRS QRS Complex Complex RR PP ST ST segment segment
Atrial Fibrillation Management Across the Spectrum of Illness
Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated
Recurrent AF: Choosing the Right Medication.
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department
Atrial fibrillation (AF) care pathways. for the primary care physicians
Atrial fibrillation (AF) care pathways for the primary care physicians by University of Minnesota Physicians Heart, October, 2011 Evaluation by the primary care physician: 1. Comprehensive history and
Ngaire has Palpitations
Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.
SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE
SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE Summary Heart failure has a worse prognosis than many cancers with an annual mortality of 40% in the first year following diagnosis and 10% thereafter.
Normal Sinus Rhythm. Sinus Bradycardia. Sinus Tachycardia. Rhythm ECG Characteristics Example (NSR) & consistent. & consistent.
Normal Sinus Rhythm (NSR) Rate: 60-100 per minute Rhythm: R- R = P waves: Upright, similar P-R: 0.12-0.20 second & consistent P:qRs: 1P:1qRs Sinus Tachycardia Exercise Hypovolemia Medications Fever Hypoxia
Atrial Fibrillation The Basics
Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services NEW product from the Medicare Learning Network (MLN) Provider Compliance Tips for Computed Tomography (CT) Scans Podcast,
Worldwide Experience with S-ICD: Early results from the EFFORTLESS Registry
Worldwide Experience with S-ICD: Early results from the EFFORTLESS Registry Results published in European Heart Journal (March 2014) Pier D. Lambiase, Craig Barr, Dominic A.M.J. Theuns, Reinoud Knops,
Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
Heart Failure Outpatient Clinical Pathway
Heart Failure Outpatient Clinical Pathway PHASE 1: PHASE 2: PHASE 3: PHASE 4: Initial Consult and Treatment Optimization of Therapy Reassessment and Further Optimization Maintenance I. Provider II. Consults
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? Indiana Chapter-ACC 17 th Annual Meeting Indianapolis, Indiana October 19, 2013 Deepak Bhakta MD FACC FACP FAHA FHRS CCDS Associate
2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.
DISCLOSURES I have no relevant financial relationships to disclose. Cardiac Evaluation of Potential Solid Organ Transplant Recipients Michele Hamilton, MD Director, Heart Failure Program Cedars Sinai Heart
ST Segment Elevation Nothing is ever as hard (or easy) as it looks
ST Segment Elevation Nothing is ever as hard (or easy) as it looks Cameron Guild, MD Division of Cardiology University of Mississippi Medical Center February 17, 2012 Objectives 1. Describe the electrical
CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014
CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 e 55 0495 2 Emergency Department (ED)- 1 Emergency Department Throughput Median time from
Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)
Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI) Highlights from Prescribing Information - the link to the full text PI is as follows: http://www.pharma.us.novartis.com/product/pi/pdf/gilenya.pdf
Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona
Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary
Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015
Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015 Disclaimer I have no relationships to disclose Do we have a cure for Atrial Fibrillation? The short
PRACTICAL APPROACH TO SVT. Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia
PRACTICAL APPROACH TO SVT Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia CONDUCTION SYSTEM OF THE HEART SA node His bundle Left bundle AV node Right
Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology
Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Chapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89) The diabetes mellitus codes are combination codes
TABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours)
Clinical Practice Guidelines for the Management of Patients With Atrial Fibrillation Deborah Ritchie RN, MN, Robert S Sheldon MD, PhD Cardiovascular Research Group, University of Calgary, Alberta Partly
MRI Case Study MRI Cervical Spine
MRI Case Study MRI Cervical Spine Jewish Hospital Louisville, KY The Revo MRI SureScan pacing system is MR Conditional designed to allow patients to undergo MRI under the specified conditions for use.
ACTION Registry GWTG Version 2.4
ACTION Registry GWTG Version 2.4 Dr. Joanne Foody Kim Hustler The following relationships exist: Dr. Foody:Janssen, Sanofi, Genzyme, Aegerion, Amarin, BristolMeyersSquibb, Abbott, Gilead, ACC, Pfizer,
Management of Atrial Fibrillation in Heart Failure
Disadvantages of AV Junction Ablation Persistent AFib- no AV synchrony Ongoing risk of thromboembolism Life-long dependency on pacemaker Comparison of LA Ablation vs. AVN Ablation LA Ablation AVN Ablation
MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY
MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY In order to improve the efficiency of PINNACLE Registry data analytics, a missing data analysis has been conducted on PINNACLE Registry data
«Δυσλειτουργία βηματοδότη. Πως μπορούμε να την εκτιμήσουμε στο ιατρείο.» Koσσυβάκης Χάρης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ
«Δυσλειτουργία βηματοδότη. Πως μπορούμε να την εκτιμήσουμε στο ιατρείο.» Koσσυβάκης Χάρης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ Diagnostic tools History: symptoms, physical examination 12 leads ECG,
Potential Causes of Sudden Cardiac Arrest in Children
Potential Causes of Sudden Cardiac Arrest in Children Project S.A.V.E. When sudden death occurs in children, adolescents and younger adults, heart abnormalities are likely causes. These conditions are
What Are Arrhythmias?
What Are Arrhythmias? Many people have questions about what the word arrhythmia means, and arrhythmias can be a difficult subject to understand. The text below should give you a better understanding of
Tachyarrhythmias (fast heart rhythms)
Patient information factsheet Tachyarrhythmias (fast heart rhythms) The normal electrical system of the heart The heart has its own electrical conduction system. The conduction system sends signals throughout
12-Lead EKG Interpretation. Judith M. Haluka BS, RCIS, EMT-P
12-Lead EKG Interpretation Judith M. Haluka BS, RCIS, EMT-P ECG Grid Left to Right = Time/duration Vertical measure of voltage (amplitude) Expressed in mm P-Wave Depolarization of atrial muscle Low voltage
Treatments to Restore Normal Rhythm
Treatments to Restore Normal Rhythm In many instances when AF causes significant symptoms or is negatively impacting a patient's health, the major goal of treatment is to restore normal rhythm and prevent
PVC s / PAC s What Do They Mean? What Should You Do? Jeffrey H. Neuhauser, D.O.,F.A.C.C. BHHI Primary Care Symposium February 27, 2015
PVC s / PAC s What Do They Mean? What Should You Do? Jeffrey H. Neuhauser, D.O.,F.A.C.C. BHHI Primary Care Symposium February 27, 2015 Financial disclosures Paid speaker for Pfizer Learning Objectives
Quiz 4 Arrhythmias summary statistics and question answers
1 Quiz 4 Arrhythmias summary statistics and question answers The correct answers to questions are indicated by *. All students were awarded 2 points for question #2 due to no appropriate responses for
Episode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier
Episode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier Most common dysrhythmia seen in ED, and incidence increasing with ageing population Presentation Common presentations: younger patients often
Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC
Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC The Federal Motor Carrier Safety Administration (FMCSA) administers the Federal Motor Carrier Safety Regulations (FMCSRs)
Visited 9/14/2011. What is Atrial Fibrillation? What you need to know about Atrial Fibrillation. The Normal Heart Rhythm. 1 of 7 9/14/2011 10:50 AM
1 of 7 9/14/2011 10:50 AM Current URL: What you need to know about Atrial Fibrillation What is atrial fibrillation? What causes atrial fibrillation? How is atrial fibrillation diagnosed? What are the dangers
Antiplatelet and Antithrombotics From clinical trials to guidelines
Antiplatelet and Antithrombotics From clinical trials to guidelines Ashraf Reda, MD, FESC Prof and head of Cardiology Dep. Menofiya University Preisedent of EGYBAC Chairman of WGLVR One of the big stories
Michael Hartman, CRNA, DNP, MSN, BSN, BA
Michael Hartman, CRNA, DNP, MSN, BSN, BA Intrinsic Conduction Automaticity-cardiac cells ability to spontaneously depolarize and initiate impulse Depolarization-cardiac cells go to a+ intracellular and
Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology
Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of
the basics Perfect Heart Institue, Piyavate Hospital
ECG INTERPRETATION: the basics Damrong Sukitpunyaroj MD Damrong Sukitpunyaroj, MD Perfect Heart Institue, Piyavate Hospital Overview Conduction Pathways Systematic Interpretation Common abnormalities in
MADIT-II CLINICAL SUMMARY
CAUTION: Federal law restricts this device to sale by or on the order of a physician trained or experienced in device implant and follow-up procedures. CLINICAL SUMMARY MADIT-II Boston Scientific Corporation
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
Atrial fibrillation. Quick reference guide. Issue date: June 2006. The management of atrial fibrillation
Quick reference guide Issue date: June 2006 Atrial fibrillation The management of atrial fibrillation Developed by the National Collaborating Centre for Chronic Conditions Contents Contents Patient-centred
INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES
INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES NOTICE: This is an introductory guide for a user to understand basic ECG tracings and parameters. The guide will allow user to identify some of the
Premature Ventricular Contractions. Ralph Augostini, MD FACC FHRS
Premature Ventricular Contractions Ralph Augostini, MD FACC FHRS Orlando, Florida October 7-9, 2011 Premature Ventricular Contractions: ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular
Treatment Options for Atrial Fibrillation Patient Information
Patient Information Treatment Options for Atrial Fibrillation Page 1 of 8 Treatment Options for Atrial Fibrillation Patient Information Emory University Hospital Midtown Cardiac Electrophysiology Service
Introduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center
Introduction to Electrophysiology Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center Objectives Indications for EP Study How do we do the study Normal recordings Abnormal Recordings Limitations
PRO-CPR. 2015 Guidelines: PALS Algorithm Overview. (Non-AHA supplementary precourse material)
PRO-CPR 2015 Guidelines: PALS Algorithm Overview (Non-AHA supplementary precourse material) Please reference Circulation (from our website), the ECC Handbook, or the 2015 ACLS Course Manual for correct
Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Management of Patients With. Learn and Live SM. ACC/AHA/ESC Pocket Guideline
Learn and Live SM ACC/AHA/ESC Pocket Guideline Based on the ACC/AHA/ESC 2006 Guidelines Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death September 2006 Special
DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
Presenter Disclosure Information
2:15 3 pm Managing Arrhythmias in Primary Care Presenter Disclosure Information The following relationships exist related to this presentation: Raul Mitrani, MD, FACC, FHRS: Speakers Bureau for Medtronic.
Managing the Patient with Atrial Fibrillation
Pocket Guide Managing the Patient with Atrial Fibrillation Updated April 2012 Editor Stephen R. Shorofsky, MD, Ph.D. Assistant Editors Anastasios Saliaris, MD Shawn Robinson, MD www.hrsonline.org DEFINITION
Demographics. MBSAQIP Case Number: IDN: ACS NSQIP Case Number:
Demographics *LMRN: *DOB: / / *Gender: Male Female *Race: White Native Hawaiian/Other Pacific Islander Black or African American Asian American Indian or Alaska Native Unknown *Hispanic Ethnicity: Unknown
Remote Monitoring of Cardiac Implantable Electrical Devices (CIEDs)
Remote Monitoring of Cardiac Implantable Electrical Devices (CIEDs) Changing the face of enhanced self-management and improved coordinated healthcare K Fan, CKC Tsui, KL Au, RTC Ng, CYS Chung, KW Lai,
1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA
1p36 and the Heart John Lynn Jefferies, MD, MPH, FACC, FAHA Director, Advanced Heart Failure and Cardiomyopathy Services Associate Professor, Pediatric Cardiology and Adult Cardiovascular Diseases Associate
National CRM Database Future Directions. Francis Murgatroyd King s College Hospital, London
National CRM Database Future Directions Francis Murgatroyd King s College Hospital, London Questions What is NICOR, and what happened to CCAD? Why are the databases changing? What changes are being made?
Patient Information Sheet Electrophysiological study
Patient Information Sheet Electrophysiological study Your doctor has recommended performing an electrophysiological study (also called EPS). EPS is a diagnostic procedure designed to test and evaluate
Acquired, Drug-Induced Long QT Syndrome
Acquired, Drug-Induced Long QT Syndrome A Guide for Patients and Health Care Providers Sudden Arrhythmia Death Syndromes (SADS) Foundation 508 E. South Temple, Suite 202 Salt Lake City, Utah 84102 800-STOP
Cardiovascular System & Its Diseases. Lecture #4 Heart Failure & Cardiac Arrhythmias
Cardiovascular System & Its Diseases Lecture #4 Heart Failure & Cardiac Arrhythmias Dr. Derek Bowie, Department of Pharmacology & Therapeutics, Room 1317, McIntyre Bldg, McGill University [email protected]
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence
NCDR ACTION Registry -GWTG v2.4 Coder's Data Dictionary
A. Demographics Seq. #: 2000 Name: Last Name Coding Instructions: Indicate the patient's last name. Hyphenated names should be recorded with a hyphen. This element is referenced in The Joint Commission
